期刊文献+

CT引导下无水乙醇消融治疗侵犯胸膜或胸壁的恶性肿瘤 被引量:1

CT-guided percutaneous ethanol ablation in the treatment of malignancies with pleural or chest wall invasion
原文传递
导出
摘要 目的探讨CT引导下无水乙醇消融(PEA)治疗侵犯胸膜或胸壁恶性肿瘤的可行性及其临床疗效。方法9例侵犯胸膜或胸壁的恶性肿瘤患者,均采用CT引导下经皮穿刺无水乙醇消融治疗,观察其生活质量改善情况及应用CT扫描评价其治疗效果。结果PEA治疗成功后所有患者癌性疼痛得到缓解,疼痛评分减低到0~3分,患者的咳嗽、咯血症状消失,食欲、睡眠明显改善,体重增加,KPS评分达90分以上。患者术中及术后无严重不良反应和并发症。全组9例患者首程治疗18个病灶,经34次PEA治疗后获得消融成功。1例转移性胸膜间皮瘤患者和1例肝癌胸膜转移瘤患者在PEA成功后随访中出现病灶局部复发和新发病灶,继续PEA治疗取得良好疗效。1例肺癌患者于PEA治疗成功后第8个月肿瘤复发,再行2次PEA治疗后肿瘤得到控制,另1例肺癌患者PEA成功后第6个月肿瘤复发但放弃治疗。全组中位随访11个月(6—24个月)。2例原发肝癌患者于治疗后第8个月和第9个月死于脑转移,其余病人仍在随访之中。结论CT引导下无水乙醇消融治疗侵犯胸膜或胸壁的恶性肿瘤应用方便、对患者的创伤小,临床疗效确切,并发症少,不良反应轻,可明显改善癌症患者的生活质量。因此,对无手术适应证以及术后、放化疗后有残留、复发的侵犯胸膜或胸壁的恶性肿瘤患者,PEA治疗是一种很好的治疗选择。 Objective To explore the feasibility and efficiency of CT-guided percutaneous ethanol ablation (PEA) in the treatment of malignant tumors with pleural or chest wall invasion. Methods Nine patients of malignant tumors with pleural or chest wall invasion that failed to respond to operation, radiotherapy, or chemotherapy were treated by PEA under CT guidance. The improvement of quality of life (QOL) during the treatment was observed and the efficiency was evaluated by CT scan. Follow-up was conducted for 6 - 24 months. Results After successful ethanol ablation, cancer pain of the patients was relieved obviously and pain degree reduced to 0 -3 score according to the numerical rating scale (NRS). Cough and hemoptysis disappeared. Appetite and sleeping were improved markedly. Body weight increased and the Karnofsky performance status (KPS) score was over 90. No serious adverse effect and complication occurred during and after PEA. PEA was performed successfully 34 times in 18 lesions of these 9 patients. In follow-up, local recurrence and new tumors appeared in 2 patients, but good results were achieved after the second PEA treatment. One tumor came to recurrence in a patient of lung cancer, but it was well controlled after another two times of PEA treatment. One patient with lung cancer gave up treatment and came to recurrence after successful PEA treatment 7 months later. Two patients of primarily hepatocellular carcinoma died of brain metastases 8 and the 9 months after treatment. Conclusion With little damage and few complications, CT-guided PEA is convenient and effective in treatment of malignant tumors with pleural invasion.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第47期3365-3368,共4页 National Medical Journal of China
关键词 胸膜 肿瘤 导管消融术 乙醇 Pleura Neoplasms Catheter ablation Ethanol
  • 相关文献

参考文献12

  • 1于振国,袁淦宁,李炽锋.侵犯胸壁179例非小细胞肺癌的外科治疗[J].中华肿瘤防治杂志,2006,13(22):1741-1743. 被引量:2
  • 2Matsuoka H, Nishio W, Okada M, et al. Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg,2004 ,26 :1200-1204.
  • 3Roviaro G, Varoli F, Grignani F, et al. Non-small cell lung cancer with chest wall invasion : evolution of surgical treatment and prognosis in the last 3 decades. Chest,2003,123:1341-1347.
  • 4李泽坚.肺癌的现代外科治疗及存在的问题[J].中华医学杂志,2005,85(37):2595-2597. 被引量:7
  • 5王小震,李宁,王绿化,李晔雄.恶性胸膜间皮瘤的临床研究进展[J].癌症进展,2006,4(1):20-26. 被引量:25
  • 6Vogelzang NJ , Rusthoven JJ , Symanowski J , et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatinalone in patients with malignant pleural mesothelioma. J Clin Oncol , 2003 , 21:2636-2644.
  • 7Smith IE, O' Brian ME, Talbot DC, et al. Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol, 2001,19:1336-1343.
  • 8Stinchcombe TE, Fried D, Morris DE, et al. Combined modality therapy for stage III non-small cell lung cancer. Oncologist, 2006,11 : 809-823.
  • 9Lencioni R, Pinto F, ArmiIIotta N, et al. Long-term resuhs of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis : a European experience. Eur Radiol, 1997, 7 : 514- 519.
  • 10Kurokohchi K, Masaki T, Miyauchi Y,et al. Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma. Int J Oncol, 2004 , 24: 381-387.

二级参考文献49

  • 1王云华,刘顾岗,黄世章,徐斐,杨树仁.无水酒精瘤内注射结合灌注化疗治疗周围型肺癌初步探讨[J].临床放射学杂志,1994,13(6):366-369. 被引量:17
  • 2方立德.剖胸未切除的肺癌经肺动脉介入治疗后再手术的体会[J].医师进修杂志,1996,19(6):11-12. 被引量:6
  • 3袁建华,刘子江,杨建勇.经皮肺穿刺注射无水乙醇治疗肺癌的动物实验和初步临床应用[J].临床放射学杂志,1996,15(4):239-241. 被引量:24
  • 4Shiina S,Tagawa K,Niwa Y,et al.Percutaneous ethanol injection therapy for hepatocellular carcinoma:results in 146 patients[J].AJR Am J Roentgenol,1993,160(5):1023.
  • 5Vehmas T,TapaniE.Echogenicity of experimental liver ethanol injections[J].Ultrasound Med Biol,1995,21(9):1137.
  • 6Bartolozzi C,Lencioni R,Caramella D,et al.Treatment of large HCC:transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization[J].Radiology,1995,197(3):812.
  • 7Koda M,Murawaki Y,Mitsuda M,et al.Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma:a randomized control study[J].Cancer,2001,92(6):1516.
  • 8Livarghi T.Radiofrequency ablation,PEIT,and TACE for hepatocellular carcinoma[J].J Hepatobiliary Pancreat Surg,2003,10(1):67.
  • 9Westcott J L.Percutaneous transthoracic needle biopsy[J].Radiology,1988,169(3):539.
  • 10Sinner W N,Zajicek J.Implantation metastasis after percutaneous transthoracic needle aspiration biopsy[J].Acta Radiol Diagn,1976,17(4):473.

共引文献35

同被引文献21

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部